United States· US:63029-910_723c2251-679b-4648-9fbb-a8521db2eb7f
Dramamine for Kids
A dimenhydrinate product containing dimenhydrinate, registered in United States by Medtech Products Inc.. The same ATC class is registered in 9 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Dimenhydrinate is registered in 9 of 19 countries.
Countries holding a registration under ATC R06AA11 (dimenhydrinate), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 4 of them publish a price we can compare per daily dose
Dimenhydrinate · ATC R06AA11
9 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Franceprice
- Germany
- Japan
- Norwayprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dimenhydrinate costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.
- United States: $0.34 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Dimenhydrinate · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- US United States$0.34 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DIMENHYDRINATE
- Manufacturer
- Medtech Products Inc.
- Country
- United States (US)
- ATC code
- R06AA11
- ATC class
- Dimenhydrinate
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1163029910011 BLISTER PACK in 1 CASE (63029-910-01) / 8 TABLET, CHEWABLE in 1 BLISTER PACK
- ndc1163029-910-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
85 interactions on record for dimenhydrinate.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dimenhydrinate · interactions on record
85 records
- 3 severe
- 81 moderate
- 1 minor
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- DicycloverineA03AA07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dimenhydrinate in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyDimenhydrinat AlAliud Pharma Gmbh
- CanadaANTI-NAUSEANTVITA HEALTH PRODUCTS INC
- SpainBIODRAMINA 100 mg SUPOSITORIOSUriach Aquilea Otc, S.L.
- NorwayDimenhydrinat aluidAliud Pharma
- BelgiumArlevertan 20 mg - 40 mgHennig Arzneimittel
- PolandAviomarinTeva Pharmaceuticals Polska Sp. z o.o.
- United KingdomDimenhydrinate 12.5mg/5ml oral solutionSpecial Order
- FranceNAUSICALM 15,7 mg ENFANTS, sirop en sachetBROTHIER
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Travelgum, Vertirosan
- Belgium · R Calm, R Calm Dimenhydrinate
- Bulgaria · Вомакур, Дименхидринат Актавис
- Cyprus · Oriens Vom, Travelgum 20mg
- Germany · Dimenhydrinat Al, Dimenhydrinat Hameln
- Denmark · Dimenhydrinat Galenica
- Spain · Biodramina, Biodramina Infantil
- France · Nausicalm, Nausicalm Adultes
- United Kingdom (Northern Ireland) · Travlese
- Greece · Travelgum 20mg, Vomex-A
- Croatia · Dramina
- Hungary · Daedalon, Daedalon Kid
- Italy · Lomarin, Novago
- Luxembourg · Dimenhydrinat Hameln, Vomex A
- Latvia · Vertirosan
- Malta · Biodramina, Vomidrine
- Poland · Aviomarin
- Portugal · Draminal, Enjomin
- Romania · Oriens
- Sweden · Calma
- Slovenia · Dramina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/068e2263-0d29-4fc6-9de5-df6a3ee534a9 GET /v1/drugs/068e2263-0d29-4fc6-9de5-df6a3ee534a9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "25",
"substance": "DIMENHYDRINATE",
"productndc": "63029-910",
"dosage_form": "TABLET, CHEWABLE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "M009",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about dimenhydrinate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.